Who owns Morphosys Ag Adr?
- Ticker: MOR
- CUSIP Number: 617760202
Tip: Access positions for across all investors
Analyze quarterly positions in Morphosys with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Morphosys stock
Who bought or sold Morphosys Ag Adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Kynam Capital Management | 4.2M | $42M | 100% | Dec 2023 |
|
| Point72 Asset Management | 3.8M | $38M | 2075% | Dec 2023 |
|
| T. Rowe Price Associates | 2.7M | $27M | 100% | Dec 2023 |
|
| Logos Global Management | 2.5M | $25M | 161% | Dec 2023 |
|
| Caption Management | 419k | $4.1M | 100% | Dec 2023 |
|
| Ikarian Capital | 400k | $4.0M | 100% | Dec 2023 |
|
| TD Asset Management | 361k | $3.6M | 154% | Dec 2023 |
|
| Citadel Advisors | 350k | $3.5M | 122% | Dec 2023 |
|
| Millennium Management | 330k | $3.3M | 2036% | Dec 2023 |
|
| Marshall Wace | 326k | $3.2M | 100% | Dec 2023 |
|
| Goldman Sachs Group | 276k | $2.7M | 594% | Dec 2023 |
|
| TIG Advisors | 245k | $2.4M | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 196k | $1.9M | 682% | Dec 2023 |
|
| Two Sigma Investments | 186k | $1.8M | 100% | Dec 2023 |
|
| Opaleye Management | 145k | $1.4M | -88% | Dec 2023 |
|
| Hennion & Walsh Asset Management | 117k | $2.1M | 71% | Mar 2024 |
|
| Jane Street | 102k | $961k | 100% | Dec 2023 |
|
| Gts Securities | 51k | $503k | 100% | Dec 2023 |
|
| Henry James International Management | 43k | $426k | 100% | Dec 2023 |
|
| Squarepoint Ops | 37k | $362k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 32k | $320k | 100% | Dec 2023 |
|
| Balyasny Asset Management | 32k | $313k | 100% | Dec 2023 |
|
| Virtu Financial | 25k | $244k | 100% | Dec 2023 |
|
| Exchange Traded Concepts | 16k | $288k | -9% | Mar 2024 |
|
| Cutler | 15k | $0 | -73% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 14k | $140k | 2% | Dec 2023 |
|
| Bank of America Corporation | 5.6k | $55k | 30% | Dec 2023 |
|
| Quadrant Capital | 5.6k | $55k | 205% | Dec 2023 |
|
| Simplex Trading | 4.9k | $88k | -96% | Mar 2024 |
|
| Rhumbline Advisers | 3.8k | $38k | 217% | Dec 2023 |
|
| Wells Fargo & Company | 2.7k | $27k | -95% | Dec 2023 |
|
| Signature | 2.6k | $26k | -2% | Dec 2023 |
|
| GAMMA Investing | 1.9k | $35k | 24% | Mar 2024 |
|
| Parallel Advisors | 1.5k | $15k | 339% | Dec 2023 |
|
| Us Bancorp | 1.3k | $13k | 95% | Dec 2023 |
|
| Lindbrook Capital | 1.2k | $23k | 8% | Mar 2024 |
|
| UBS Group | 800.00 | $7.9k | -11% | Dec 2023 |
|
| Nbc Securities | 695.00 | $12k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 200.00 | $2.0k | 0% | Dec 2023 |
|
| Ronald Blue Trust | 39.00 | $0 | 100% | Dec 2023 |
|
| Advisor Group Holdings | 9.00 | $89.000100 | -18% | Dec 2023 |
|
Who sold out of Morphosys?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Hudson Bay Capital Management | Sep 2023 | 455k | $3.1M |
| AlphaCentric Advisors | Sep 2023 | 185k | $1.2M |
| Jpmorgan Chase & Co | Sep 2023 | 40k | $267k |
| Schonfeld Strategic Advisors | Sep 2023 | 28k | $186k |
| Bell Investment Advisors | Sep 2023 | 160.00 | $1.1k |